CMS’s (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions

SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that the preclinical results of its self-developed innovative INHBE-targeting small nucleic acid drug CMS-D008 injection (“CMS-D008”), have been presented in a poster at the… Continue Reading

From Coding Between Orders to a Full Software Ecosystem: Charlotte-Area Black Founder Has Spent Nearly Two Decades Building Technology for the Small Operator

What began in 2008 as a self-taught faith leader building streaming tools so churches could reach wider audiences has grown into Guru Boxz Technologies — a portfolio of software and marketplace products that founder TR Burns architects and ships himself,… Continue Reading